Ernst & Young Names BioMarin CEO Jean-Jacques Bienaime EY Entrepreneur Of The Year® 2015 National Award Winner in Life Scien...
November 16 2015 - 8:00AM
BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that
Ernst & Young Global Limited awarded BioMarin CEO Jean-Jacques
Bienaimé the EY Entrepreneur Of The Year® 2015 National Award in
the Life Sciences category. The award recognizes outstanding
entrepreneurs who demonstrate excellence and extraordinary success
in such areas as innovation, financial performance, and personal
commitment to their businesses and communities. Jean-Jacques
Bienaimé was selected by an independent panel of judges, and was
honored at the EY Entrepreneur Of The Year National Awards gala on
Nov. 14, 2015, the culminating event of the EY Strategic Growth
Forum® in Palm Springs, California. The Forum is the nation’s
premier gathering of high-growth, market-leading companies.
“This distinguished recognition of our commitment to patients
with rare genetic diseases would not be possible, if it weren’t for
BioMarin employees, the patients that we serve, the medical
professionals with whom we partner and the communities where we
operate,” said Jean-Jacques Bienaimé, Chairman and CEO of
BioMarin. “Our laser-like focus on translating science from
the laboratory into medical treatments for patients with rare
genetic diseases allows us to make a big difference for a small
number of patients, who often are children with few, if any,
treatment options.”
BioMarin is one of the largest independent biotechs in the
Northern California and one of the largest employers overall in
Marin County, home to the biotech company since 1997. With
more than 2,000 employees worldwide and growing, BioMarin is
actively hiring, particularly people with medical and scientific
backgrounds.
The EY Entrepreneur Of The Year Award recognizes visionary
business leaders who demonstrate innovation, financial success and
commitments to their communities as they create and build
world-class companies. The EY Entrepreneur Of The Year Award
winners are selected by an independent panel of judges from more
than 250 regional award recipients. Awards for entrepreneurial
excellence were given in 11 categories.
About EY Entrepreneur Of The Year®
EY Entrepreneur Of The Year® is the world’s most prestigious
business awards program for entrepreneurs. The program makes a
difference through the way it encourages entrepreneurial activity
among those with potential and recognizes the contribution of
people who inspire others with their vision, leadership and
achievement. As the first and only truly global awards program of
its kind, Entrepreneur Of The Year celebrates those who are
building and leading successful, growing and dynamic businesses,
recognizing them through regional, national and global awards
programs in more than 145 cities in more than 60 countries.
ey.com/eoy.
Now in its 29th year, the program has honored the inspirational
leadership of such entrepreneurs as Howard Schultz of Starbucks
Coffee Company, Pierre Omidyar of eBay, Inc., and Mindy Grossman of
HSN. Recent US national winners include Reid Hoffman and Jeff
Weiner of LinkedIn; Hamdi Ulukaya, founder of Chobani; and Dr.
David Hung, President and CEO and Chairman of Medivation.
As a Northern California award winner, BioMarin became eligible
for consideration for the Entrepreneur Of The Year 2015 national
program. Award winners in national categories were announced at the
annual awards gala in Palm Springs, California, on November 14,
2015. The awards are the culminating event of the EY Strategic
Growth Forum®, the nation’s most prestigious gathering of
high-growth, market-leading companies.
About BioMarin
BioMarin is a global biotechnology company that
develops and commercializes innovative therapies for patients with
serious and life-threatening rare and ultra-rare genetic diseases.
The company's portfolio consists of five commercialized products
and multiple clinical and pre-clinical product candidates. For
additional information, please visit www.BMRN.com.
About EY
EY is a global leader in assurance, tax, transaction and
advisory services. The insights and quality services we deliver
help build trust and confidence in the capital markets and in
economies the world over. We develop outstanding leaders who team
to deliver on our promises to all of our stakeholders. In so doing,
we play a critical role in building a better working world for our
people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or
more, of the member firms of Ernst & Young Global Limited, each
of which is a separate legal entity. Ernst & Young Global
Limited, a UK company limited by guarantee, does not provide
services to clients. For more information about our organization,
please visit ey.com.
BioMarin® is a registered trademark of BioMarin
Pharmaceutical Inc.
Contact:
Investors:
Traci McCarty
BioMarin Pharmaceutical Inc.
(415) 455-7558
Media:
Debra Charlesworth
BioMarin Pharmaceutical Inc.
(415) 455-7451
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Apr 2023 to Apr 2024